Progranulin levels in blood in Alzheimer's disease and mild cognitive impairment
Abstract
Changes in progranulin (GRN) expression have been hypothesized to alter risk for Alzheimer's disease (AD). We investigated the relationship between GRN expression in peripheral blood and clinical diagnosis of AD and mild cognitive impairment (MCI).
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 02, 2018
- Source ID
- 10.1002/acn3.560
Entities
People
- Adam L. Boxer
- Anna M. Karydas
- Binbin Yue
- Bruce L. Miller
- Daniel Nachun
- Deepika Dokuru
- Ginette Serrero
- Giovanni Coppola
- The Alzheimer’s Disease Neuroimaging Initiative*
- Yonatan A. Cooper
- Zhongan Yang
Organizations
- Alzheimer's Disease Research Foundation
- Alzheimer's Foundation of America
- National Cancer Institute
- National Heart, Lung, and Blood Institute
- National Human Genome Research Institute
- National Institute of Mental Health
- National Institute of Neurological Disorders and Stroke
- National Institute on Aging
- National Institute on Drug Abuse
- National Institutes of Health
- United States Department of Defense
- University of California, Los Angeles
- University of California, San Francisco